SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-14-072278
Filing Date
2014-10-17
Accepted
2014-10-17 17:03:40
Documents
3
Period of Report
2014-12-01

Document Format Files

Seq Description Document Type Size
1 PRE 14A a14-14205_6pre14a.htm PRE 14A 435557
2 GRAPHIC g142056bgi001.jpg GRAPHIC 4789
3 GRAPHIC g142056bci001.jpg GRAPHIC 6023
  Complete submission text file 0001104659-14-072278.txt   451786
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PRE 14A | Act: 34 | File No.: 000-55020 | Film No.: 141162389
SIC: 2834 Pharmaceutical Preparations